Unlock this StockReport nowClick to Unlock

Verona Pharma Reuters News

VRP 58.5p 0.0  0.0%
22/05/19 2.00k
StockRank



Mon 3:16pm Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at American Thoracic Society 2019 International Conference
Mon 3:16pm Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at American Thoracic Society 2019 International Conference
7th May Result of AGM
7th May BRIEF-Verona Pharma Initiates Additional Phase 2B Clinical Trial With Nebulized Ensifentrine To Inform Dose Selection For Phase 3 Trials
7th May Verona Pharma plc Operational Update and Financial Results for the Three Months Ended March 31, 2019
7th May Verona Pharma Initiates Additional Phase 2b Clinical Trial with Nebulized Ensifentrine to Inform Dose Selection for Phase 3 Trials
7th May Verona Pharma plc Operational Update and Financial Results for the Three Months Ended March 31, 2019
7th May Verona Pharma Initiates Additional Phase 2b Clinical Trial with Nebulized Ensifentrine to Inform Dose Selection for Phase 3 Trials
2nd May Verona Pharma to Present Clinical Trial Data of Ensifentrine for COPD Maintenance Treatment at American Thoracic Society 2019 International Conference
2nd May Verona Pharma to Present Clinical Trial Data of Ensifentrine for COPD Maintenance Treatment at American Thoracic Society 2019 International Conference
1st May Verona Pharma to Announce Financial Results for First Quarter Ended March 31, 2019 and Provide Clinical Development Update
1st May Verona Pharma plc ("Verona" or the "Company") Appointment of Nominated Adviser and UK Broker
1st May Verona Pharma to Announce Financial Results for First Quarter Ended March 31, 2019 and Provide Clinical Development Update
1st May Verona Pharma plc ("Verona" or the "Company") Appointment of Nominated Adviser and UK Broker
25th Apr Verona Pharma to Host Investor & Analyst R&D Forum in London on May 8, 2019
25th Apr Verona Pharma to Host Investor & Analyst R&D Forum in London on May 8, 2019
9th Apr BRIEF-Verona Pharma Granted EU Patent For Late-Stage COPD Clinical Candidate Ensifentrine
9th Apr BRIEF-Verona Pharma Granted EU Patent Related To Late-Stage COPD Clinical Candidate Ensifentrine
9th Apr Verona Pharma Granted Key EU Patent Related to Late-stage COPD Clinical Candidate Ensifentrine
9th Apr Verona Pharma Granted Key EU Patent Related to Late-stage COPD Clinical Candidate Ensifentrine


Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis